NURSE OWNED AND OPERATED
OLIVE'S BRANCH does NOT distribute medicine
Copyright © Olive's Branch 2019
Review is set to be completed by the end of June 2018.
"Epidiolex, GW's lead cannabinoid product candidate is a pharmaceutical formulation of purified cannabidiol (CBD), which is in development for the treatment of several rare childhood-onset epilepsy disorders. GW has submitted a New Drug Application with the FDA for Epidiolex as adjunctive treatment for seizures associated with LGS and Dravet syndrome with an expected approval and launch in 2018. "